Press Resease

Apoptosis Assays Market - Global Industry Analysis

Apoptosis Assays Market by Product (Assay Kit, Reagent, Instruments, and Microplates), By Detection Technology (Flow Cytometry, Fluorescence Microscopy, and Others), By Application (Drug Discovery and Development, Clinical Research, Stem Cell Research, and Basic Research), and by End-User (Pharmaceutical and Biotechnology Companies, Diagnostic Labs, Hospitals, and Academic and Research Institutes): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 14-Jun-2019 Category: Biotechnology Report Format : PDF Pages: 110 Report Code: ZMR-4217 Status : Published

Global apoptosis assays market expected to generate around USD 6.96 billion by 2025, at a CAGR of around 10% between 2019 and 2025. The rising prevalence and incidences of various infectious and chronic diseases, growing funding for research related to cancer, and rising cell-based research are likely to drive the global apoptosis assays market development.

Description

The report covers a forecast and an analysis of the apoptosis assays market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes the drivers and restraints of the apoptosis assays market along with their impact on the demand over the forecast time period. Additionally, the report includes the study of opportunities available in the apoptosis assays market on a global and regional level.

In order to give the users of this report a comprehensive view of the apoptosis assays market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Apoptosis Assays Market

The report provides company market share analysis to give a broader overview of the key players in the apoptosis assays market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the apoptosis assays market on a global and regional basis.

The study provides a decisive view of the apoptosis assays market by segmenting it based on the product, detection technology, application, end-user, and region. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

Some key players of the global apoptosis assays market include Merck KGaA, Thermo Fischer Scientific, Bio-Rad Laboratories, GE Healthcare, Geno Technology, BioTek Instruments, Biotium, Abcam, Canvax, Abnova, Creative Bioarray, Sartorius, Promega Corporation, PerkinElmer, and Danaher Corporation.

This report segments the global apoptosis assays market into:

Global Apoptosis Assays Market: By Product

  • Assay Kit
  • Reagent
  • Instruments
  • Microplates

Global Apoptosis Assays Market: By Detection Technology

  • Flow Cytometry
  • Fluorescence Microscopy
  • Others

Global Apoptosis Assays Market: By Application

  • Drug Discovery and Development
  • Clinical Research
  • Stem Cell Research
  • Basic Research

Global Apoptosis Assays Market: By End-User

  • Pharmaceutical and Biotechnology Companies
  • Diagnostic Labs
  • Hospitals
  • Academic and Research Institutes

Global Apoptosis Assays Market: By Region

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Apoptosis Assays Market, 2016-2025 (USD Billion)
    • 2.2. Global Apoptosis Assays Market: Snapshot
  •  
  • Chapter 3. Apoptosis Assays Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Apoptosis Assays Market drivers: Impact analysis
      • 3.2.2. Increasing Prevalence of chronic diseases
      • 3.2.3. Increasing Government support for R&D
    • 3.3. Market Restraints
      • 3.3.1. High capital investments
      • 3.3.2. Expensive Detection Technology
    • 3.4. Opportunities
      • 3.4.1. Emerging markets
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, By Product
      • 3.6.2. Market attractiveness analysis, By Detection Technology
      • 3.6.3. Market attractiveness analysis, By Application
      • 3.6.4. Market attractiveness analysis, By End-User
      • 3.6.5. Market attractiveness analysis, By Region
  •  
  • Chapter 4. Global Apoptosis Assays Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Apoptosis Assays Market: Company Market Share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  •  
  • Chapter 5. Global Apoptosis Assays Market - Product Analysis
    • 5.1. Global Apoptosis Assays Market: Product overview
      • 5.1.1. Global Apoptosis Assays Market revenue share, By Product, 2018 and 2025
    • 5.2. Assay Kit
      • 5.2.1. Global Apoptosis Assays Market for Assay Kit, 2016-2025 (USD Billion)
    • 5.3. Reagent
      • 5.3.1. Global Apoptosis Assays Market for Reagent, 2016-2025 (USD Billion)
    • 5.4. Instruments
      • 5.4.1. Global Apoptosis Assays Market for instruments, 2016-2025 (USD Billion)
    • 5.5. Microplates
      • 5.5.1. Global Apoptosis Assays Market for Microplates, 2016-2025 (USD Billion)
  •  
  • Chapter 6. Global Apoptosis Assays Market - Detection Technology Analysis
    • 6.1. Global Apoptosis Assays Market: Detection technology overview
      • 6.1.1. Global Apoptosis Assays Market revenue share, By Detection Technology, 2018 and 2025
    • 6.2. Flow Cytometry
      • 6.2.1. Global Apoptosis Assays Market for Flow cytometry, 2016-2025 (USD Billion)
    • 6.3. Fluorescence Microscopy
      • 6.3.1. Global Apoptosis Assays Market for Fluorescence Microscopy, 2016-2025 (USD Billion)
    • 6.4. Others
      • 6.4.1. Global Apoptosis Assays Market for Others, 2016-2025 (USD Billion)
  •  
  • Chapter 7. Global Apoptosis Assays Market - Application Analysis
    • 7.1. Global Apoptosis Assays Market: Application overview
      • 7.1.1. Global Apoptosis Assays Market revenue share, By Application, 2018 and 2025
    • 7.2. Drug Discovery and Development
      • 7.2.1. Global Apoptosis Assays Market for Drug Discovery and development, 2016-2025 (USD Billion)
    • 7.3. Clinical Research
      • 7.3.1. Global Apoptosis Assays Market for Clinical Research, 2016-2025 (USD Billion)
    • 7.4. Stem cell Research
      • 7.4.1. Global Apoptosis Assays Market for Stem Cell Research, 2016-2025 (USD Billion)
    • 7.5. Basic Research
      • 7.5.1. Global Apoptosis Assays Market for Basic Research, 2016-2025 (USD Billion)
  •  
  • Chapter 8. Global Apoptosis Assays Market - End-User Analysis
    • 8.1. Global Apoptosis Assays Market: End-User overview
      • 8.1.1. Global Apoptosis Assays Market revenue share, By End-User, 2018 and 2025
    • 8.2. Pharmaceutical and biotechnology companies
      • 8.2.1. Global Apoptosis Assays Market for Pharmaceutical and biotechnology companies, 2016-2025 (USD Billion)
    • 8.3. Diagnostic labs
      • 8.3.1. Global Apoptosis Assays Market for Diagnostic labs, 2016-2025 (USD Billion)
    • 8.4. Hospitals
      • 8.4.1. Global Apoptosis Assays Market for Hospitals, 2016-2025 (USD Billion)
    • 8.5. Academic and Research Institutes
      • 8.5.1. Global Apoptosis Assays Market for Academic and Research Institutes, 2016-2025 (USD Billion)
  •  
  • Chapter 9. Global Apoptosis Assays Market - Regional Analysis
    • 9.1. Global Apoptosis Assays Market: Regional overview
      • 9.1.1. Global Apoptosis Assays Market revenue share, By region, 2018 and 2025
    • 9.2. North America
      • 9.2.1. North America Apoptosis Assays Market Revenue, By Product, 2016-2025 (USD Billion)
      • 9.2.2. North America Apoptosis Assays Market Revenue, By detection technology, 2016-2025 (USD Billion)
      • 9.2.3. North America Apoptosis Assays Market Revenue, By Application, 2016-2025 (USD Billion)
      • 9.2.4. North America Apoptosis Assays Market Revenue, By End-User, 2016-2025 (USD Billion)
      • 9.2.5. The U.S.
        • 9.2.5.1. The U.S. Apoptosis Assays Market Revenue, By Product, 2016-2025 (USD Billion)
        • 9.2.5.2. The U.S. Apoptosis Assays Market Revenue, By detection Technology, 2016-2025 (USD Billion)
        • 9.2.5.3. The U.S Apoptosis assays Market Revenue, By Application, 2016-2025 (USD Billion)
        • 9.2.5.4. The U.S Apoptosis assays Market Revenue, By End-User, 2016-2025 (USD Billion)
      • 9.2.6. Rest of North America
        • 9.2.6.1. Rest of North America Apoptosis Assays Market Revenue, By Product, 2016-2025 (USD Billion)
        • 9.2.6.2. Rest of North America Apoptosis Assays Market Revenue, By detection Technology, 2016-2025 (USD Billion)
        • 9.2.6.3. Rest of North America Apoptosis Assays Market Revenue, By Application, 2016-2025 (USD Billion)
        • 9.2.6.4. Rest of North America Apoptosis Assays Market Revenue, By End-User, 2016-2025 (USD Billion)
    • 9.3. Europe
      • 9.3.1. Europe Apoptosis Assays Market Revenue, By Product, 2016-2025 (USD Billion)
      • 9.3.2. Europe Apoptosis Assays Market Revenue, By Detection Technology, 2016-2025 (USD Billion)
      • 9.3.3. Europe Apoptosis Assays Market Revenue, By Application, 2016-2025 (USD Billion)
      • 9.3.4. Europe Apoptosis Assays Market Revenue, By End-User, 2016-2025 (USD Billion)
      • 9.3.5. Germany
        • 9.3.5.1. Germany Apoptosis Assays Market Revenue, By Product, 2016-2025 (USD Billion)
        • 9.3.5.2. Germany Apoptosis Assays Market Revenue, By Detection Technology, 2016-2025 (USD Billion)
        • 9.3.5.3. Germany Apoptosis Assays Market Revenue, By Application, 2016-2025 (USD Billion)
        • 9.3.5.4. Germany Apoptosis Assays Market Revenue, By End-User, 2016-2025 (USD Billion)
      • 9.3.6. UK
        • 9.3.6.1. UK Apoptosis Assays Market Revenue, By Product, 2016-2025 (USD Billion)
        • 9.3.6.2. UK Apoptosis Assays Market Revenue, By Detection Technology, 2016-2025 (USD Billion)
        • 9.3.6.3. UK Apoptosis Assays Market Revenue, By Application, 2016-2025 (USD Billion)
        • 9.3.6.4. UK Apoptosis Assays Market Revenue, End-User, 2016-2025 (USD Billion)
      • 9.3.7. France
        • 9.3.7.1. France Apoptosis Assays Market Revenue, By Product, 2016-2025 (USD Billion)
        • 9.3.7.2. France Apoptosis Assays Market Revenue, By Detection Technology, 2016-2025 (USD Billion)
        • 9.3.7.3. France Apoptosis Assays Market Revenue, By Application, 2016-2025 (USD Billion)
        • 9.3.7.4. France Apoptosis Assays Market Revenue, By End-User, 2016-2025 (USD Billion)
      • 9.3.8. Rest of Europe
        • 9.3.8.1. Rest of Europe Apoptosis Assays Market Revenue, By Product, 2016-2025 (USD Billion)
        • 9.3.8.2. Rest of Europe Apoptosis Assays Market Revenue, By Detection Technology, 2016-2025 (USD Billion)
        • 9.3.8.3. Rest of Europe Apoptosis Assays Market Revenue, By Application, 2016-2025 (USD Billion)
        • 9.3.8.4. Rest of Europe Apoptosis Assays Market Revenue, By End-User, 2016-2025 (USD Billion)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific Apoptosis Assays Market Revenue, By Product, 2016-2025 (USD Billion)
      • 9.4.2. Asia Pacific Apoptosis Assays Market Revenue, By Detection Technology, 2016-2025 (USD Billion)
      • 9.4.3. Asia Pacific Apoptosis Assays Market Revenue, By Application, 2016-2025 (USD Billion)
      • 9.4.4. Asia Pacific Apoptosis Assays Market Revenue, By End-User, 2016-2025 (USD Billion)
      • 9.4.5. China
        • 9.4.5.1. China Apoptosis Assays Market Revenue, By Product, 2016-2025 (USD Billion)
        • 9.4.5.2. China Apoptosis Assays Market Revenue, By Detection Technology, 2016-2025 (USD Billion)
        • 9.4.5.3. China Apoptosis Assays Market Revenue, By Application, 2016-2025 (USD Billion)
        • 9.4.5.4. China Apoptosis Assays Market Revenue, By End-User, 2016-2025 (USD Billion)
      • 9.4.6. Japan
        • 9.4.6.1. Japan Apoptosis Assays Market Revenue, By Product, 2016-2025 (USD Billion)
        • 9.4.6.2. Japan Apoptosis Assays Market Revenue, By Detection Technology, 2016-2025 (USD Billion)
        • 9.4.6.3. Japan Apoptosis Assays Market Revenue, By Application, 2016-2025 (USD Billion)
        • 9.4.6.4. Japan Apoptosis Assays Market Revenue, By End-User 2016-2025 (USD Billion)
      • 9.4.7. India
        • 9.4.7.1. India Apoptosis Assays Market Revenue, By Product, 2016-2025 (USD Billion)
        • 9.4.7.2. India Apoptosis Assays Market Revenue, By Detection Technology, 2016-2025 (USD Billion)
        • 9.4.7.3. India Apoptosis Assays Market Revenue, By Application, 2016-2025 (USD Billion)
        • 9.4.7.4. India Apoptosis Assays Market Revenue, By End-User, 2016-2025 (USD Billion)
      • 9.4.8. Rest of Asia Pacific
        • 9.4.8.1. Rest of Asia Pacific Apoptosis Assays Market Revenue, By Product, 2016-2025 (USD Billion)
        • 9.4.8.2. Rest of Asia Pacific Apoptosis Assays Market Revenue, By Detection Technology, 2016-2025 (USD Billion)
        • 9.4.8.3. Rest of Asia Pacific Apoptosis Assays Market Revenue, By Application, 2016-2025 (USD Billion)
        • 9.4.8.4. Rest of Asia Pacific Apoptosis Assays Market Revenue, By End-User, 2016-2025 (USD Billion)
    • 9.5. Latin America
      • 9.5.1. Latin America Apoptosis Assays Market Revenue, By Product, 2016-2025 (USD Billion)
      • 9.5.2. Latin America Apoptosis Assays Market Revenue, By Detection Technology, 2016-2025 (USD Billion)
      • 9.5.3. Latin America Apoptosis Assays Market Revenue, By Application, 2016-2025 (USD Billion)
      • 9.5.4. Latin America Apoptosis Assays Market Revenue, By End-User, 2016-2025 (USD Billion)
      • 9.5.5. Brazil
        • 9.5.5.1. Brazil Apoptosis Assays Market Revenue, By Product, 2016-2025 (USD Billion)
        • 9.5.5.2. Brazil Apoptosis Assays Market Revenue, By Detection Technology, 2016-2025 (USD Billion)
        • 9.5.5.3. Brazil Apoptosis Assays Market Revenue, By Application, 2016-2025 (USD Billion)
        • 9.5.5.4. Brazil Apoptosis Assays Market Revenue, By End-User, 2016-2025 (USD Billion)
      • 9.5.6. Rest of Latin America
        • 9.5.6.1. Rest of Latin America Apoptosis Assays Market Revenue, By Product, 2016-2025 (USD Billion)
        • 9.5.6.2. Rest of Latin America Apoptosis Assays Market Revenue, By Detection Technology, 2016-2025 (USD Billion)
        • 9.5.6.3. Rest of Latin America Apoptosis Assays Market Revenue, By Application, 2016-2025 (USD Billion)
        • 9.5.6.4. Rest of Latin America Apoptosis Assays Market Revenue, By End-User 2016-2025 (USD Billion)
    • 9.6. The Middle East and Africa
      • 9.6.1. The Middle East and Africa Apoptosis Assays Market Revenue, By Product, 2016-2025 (USD Billion)
      • 9.6.2. The Middle East and Africa Apoptosis Assays Market Revenue, By Detection Technology, 2016-2025 (USD Billion)
      • 9.6.3. The Middle East and Africa Apoptosis Assays Market Revenue, By Application, 2016-2025 (USD Billion)
      • 9.6.4. The Middle East and Africa Apoptosis Assays Market Revenue, By End-User, 2016-2025 (USD Billion)
  •  
  • Chapter 10. Company Profile
    • 10.1. Merck KGaA
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Product Portfolio
      • 10.1.4. Business strategy
      • 10.1.5. Recent development
    • 10.2. Thermo Fischer Scientific
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Product Portfolio
      • 10.2.4. Business strategy
      • 10.2.5. Recent developments
    • 10.3. Bio-Rad Laboratories
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Product Portfolio
      • 10.3.4. Business strategy
      • 10.3.5. Recent developments
    • 10.4. GE Healthcare
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Product Portfolio
      • 10.4.4. Business strategy
      • 10.4.5. Recent developments
    • 10.5. Geno Technology
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Product Portfolio
      • 10.5.4. Business strategy
      • 10.5.5. Recent developments
    • 10.6. BioTek Instruments
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Product Portfolio
      • 10.6.4. Business strategy
      • 10.6.5. Recent developments
    • 10.7. Sartorius AG
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Product Portfolio
      • 10.7.4. Business strategy
      • 10.7.5. Recent developments
    • 10.8. Biotium
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Product Portfolio
      • 10.8.4. Business strategy
      • 10.8.5. Recent developments
    • 10.9. Abcam
      • 10.9.1. Overview
      • 10.9.2. Financials
      • 10.9.3. Product Portfolio
      • 10.9.4. Business strategy
      • 10.9.5. Recent developments
    • 10.10. Canvax
      • 10.10.1. Overview
      • 10.10.2. Financials
      • 10.10.3. Product Portfolio
      • 10.10.4. Business strategy
      • 10.10.5. Recent developments
    • 10.11. Abnova
      • 10.11.1. Overview
      • 10.11.2. Financials
      • 10.11.3. Product Portfolio
      • 10.11.4. Business strategy
      • 10.11.5. Recent developments
    • 10.12. Creative Bioarray
      • 10.12.1. Overview
      • 10.12.2. Financials
      • 10.12.3. Product Portfolio
      • 10.12.4. Business strategy
      • 10.12.5. Recent developments
    • 10.13. Danaher Corporation
      • 10.13.1. Overview
      • 10.13.2. Financials
      • 10.13.3. Product Portfolio
      • 10.13.4. Business strategy
      • 10.13.5. Recent developments
    • 10.14. Promega Corporation
      • 10.14.1. Overview
      • 10.14.2. Financials
      • 10.14.3. Product Portfolio
      • 10.14.4. Business strategy
      • 10.14.5. Recent developments

Methodology

Free Analysis

Apoptosis assays, in simple words, are programmed cell deaths that genetically control cell ablation during their normal development process. This is used to eliminate old, unnecessary, and unhealthy cells without releasing any harmful substances into the nearby areas. The morphological features of apoptotic cells include nuclear chromatin compaction, cytoplasm contraction, and membrane-bound apoptotic bodies’ production.

The rising prevalence and incidences of various infectious and chronic diseases, growing funding for research related to cancer, and rising cell-based research are likely to drive the global apoptosis assays market development. Moreover, on-going developments related to apoptosis-modulating drugs are expected to further propel the growth of the global apoptosis assays market over the forecast time period. However, high capital investments and expensive detection technology may restrain the growth of the apoptosis assays market. Alternatively, the wide use of apoptosis and molecular targeting therapy for the treatment of cancer and other chronic disease is also likely to support the global apoptosis assays market in the future.

Global Apoptosis Assays Market

The global apoptosis assays market is segmented on the basis of product, detection technology, application, and end-user. By product, the market includes assay kit, reagent, instruments, and microplates. The assay kit segment held the largest market share in 2018. Based on detection technology, the market is segmented into flow cytometry, fluorescence microscopy, and others. Due to the increasing adoption of cell imaging and microscopy, the flow cytometry segment contributed the largest share to the market in 2018. By application, this global market is categorized into drug discovery and development, clinical research, stem cell research, and basic research. The drug discovery and development segment held the largest market share in 2018. By end-user, the apoptosis assays market includes pharmaceutical and biotechnology companies, diagnostic labs, hospitals, and academic and research institutes.

North America dominated the global apoptosis assays market in 2018, due to the large number of scientific studies being conducted across the region, growing chronic and infectious diseases prevalence, increasing support of government bodies in the form of research investments, and the availability of high-quality infrastructure for R&D. Europe held the second spot in the global apoptosis assays market, due to the increasing cases of cancer, cardiovascular diseases, and degenerative disorders. The Asia Pacific apoptosis assays market is among the emerging markets for apoptosis assays due to the increasing number of research and development facilities in the region, growing investments in the infrastructural sector, and rising number of clinical trial drug studies.

Some key players of the global apoptosis assays market include Merck KGaA, Thermo Fischer Scientific, Bio-Rad Laboratories, GE Healthcare, Geno Technology, BioTek Instruments, Biotium, Abcam, Canvax, Abnova, Creative Bioarray, Sartorius, Promega Corporation, PerkinElmer, and Danaher Corporation.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social